Dr. Reardon serves as clinical director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute and previously served as associate deputy director of the Preston Robert Tisch Brain Tumor Center at Duke University. He completed his residency at the Johns Hopkins Hospital and a fellowship at the University of Michigan.
His expertise includes the design and implementation of clinical trials for neuro-oncology and the preclinical evaluation of promising therapeutics. His work includes evaluation of innovative clinical therapeutics with particular focus on immunotherapeutics.
Dr. Reardon has published over 200 peer-reviewed manuscripts and received the R. Wayne Rundles Award for Excellence in Cancer Research. In 2013, he was elected as the tenth president of the Society for Neuro-Oncology.
